eye issues with tirzepatide Thyroid Disease Reactivates After Using Teprotumumab Zepbound Eye Side Effects: Scientific

Diabetologia (2019) 62(7):115466

What I suggest is using this time while the noise is quieter to work on other strategies for behavior reduction and to build a strong, sustainable system to replace the behavior. Again, the clinical evidence just isnt available to make a concrete declaration about a link between nail biting and GLP-1s

instead, its best used to target specific concerns

Either way, stop listening to them

However, better depends on more than the number on the scale

The full approval came in 2022 following a head-to-head comparison of T-DXd to T-DM1, which showed significant benefits in overall survival, progression-free survival, and overall response rate in patients receiving T-DXd